Reforming 340B: Ensuring the Discount Program Delivers for Patients December 12, 2025 • 11:00 AM – 12:00 PM ET Hosted by the Alliance for Safe Biologic Medicines (ASBM) and the Global Colon Cancer Association (GCCA) Register Now The 340B Drug Discount Program was created to help hospitals and clinics stretch limited resources to serve vulnerable patients. Yet over time, the program’s lack of transparency and accountability has raised serious questions. Are these savings actually reaching the patients the program was meant to help? Join us for a live panel discussion as we examine the evolution of 340B, its current challenges, and bipartisan proposals for reform that could restore its original mission. Featured Speakers: Thomas Barker Former Deputy General Counsel U.S. Department of Health and Human Services Madelaine Feldman, M.D., FACR Vice President, Advocacy and Government Affairs Coalition of State Rheumatology Organizations (CSRO) Kathy Oubre CEO, Ponchartrain Cancer Center Andrew Spiegel Executive Director Global Colon Cancer Association (GCCA) We look forward to seeing you there!